This Government Contract opportunity from Department Of Veterans Affairs was posted on April 29, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
APOE and pTau217/pTau231 Blood Biomarker Assay Testing
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract involves performing specialized, high-sensitivity blood assays targeting APOE and pTau217/pTau231 biomarkers using de-identified human samples. This testing aims to support Alzheimer’s research by accurately distinguishing between amyloid-positive and amyloid-negative individuals, which is critical for advancing understanding of disease pathology and potentially guiding therapeutic development. The contract is a subcontract under the Department of Veterans Affairs, specifically managed by the Rpo East office, with work performed in Minneapolis. The solicitation was posted on April 29, 2026, with a response deadline of May 11, 2026. It falls under the NAICS code 541380, indicating scientific research and development services. While no specific set-aside provisions or organization types are noted, the contract emphasizes rigorous testing protocols to ensure accurate biomarker detection in support of ongoing Alzheimer’s disease studies. The location in Minneapolis likely reflects laboratory capabilities suited to this level of specialized biomedical assay work.
General Info
Agency
NAICS
Place of Performance
Minneapolis, MN, 55417, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
